Holen Sie sich die Stockscreener-App
10.57
5.49%
0.55
Handel nachbörslich:
10.35
-0.22
-2.08%
Schlusskurs vom Vortag:
$10.02
Offen:
$10.09
24-Stunden-Volumen:
543.85K
Relative Volume:
0.66
Marktkapitalisierung:
$808.07M
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-3.6574
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
+1.05%
1M Leistung:
-15.03%
6M Leistung:
-39.84%
1J Leistung:
-50.91%
1-Tages-Spanne:
$9.98
$10.98
1-Wochen-Bereich:
$9.44
$10.98
52-Wochen-Spanne:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Vergleichen Sie NRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
10.57 | 766.02M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Can Nurix Therapeutics Inc. Escape Recent Bear ChannelInvestment Strategy Designed for Capital Protection - beatles.ru
Risks Still Elevated At These Prices As Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Dive 25% - 富途牛牛
Dimensional US Core Equity 2 ETF (DFAC) Implied Analyst Target Price: $41.37, With 12.92% Upside Expected. - AInvest
Victory Capital Management Inc. Has $352,000 Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Houte Hans Van Sells 5,402 Shares - MarketBeat
Equity Inducement as a Growth Engine: How Nurix Therapeutics Aligns Talent and Shareholder Value in Biotech Innovation - AInvest
What makes Nurix Therapeutics Inc. stock price move sharplyGet exclusive market analysis for investors - Jammu Links News
Is Nurix Therapeutics Inc. stock overvalued or undervaluedUnstoppable investment returns - Jammu Links News
Nurix Therapeutics Inc. Stock Analysis and ForecastConsistent triple returns - Jammu Links News
Why is Nurix Therapeutics Inc. stock attracting strong analyst attentionHigh-yield portfolio picks - Jammu Links News
How many analysts rate Nurix Therapeutics Inc. as a “Buy”Access high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Nurix Therapeutics Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - Jammu Links News
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Insider Sells $51,739.08 in Stock - MarketBeat
What is Nurix Therapeutics Inc. company’s growth strategyCapitalize on emerging investment opportunities - Jammu Links News
What are Nurix Therapeutics Inc. company’s key revenue driversUnlock powerful trading signals for profits - Jammu Links News
Is it the right time to buy Nurix Therapeutics Inc. stockDiscover high-impact investment opportunities - Jammu Links News
Analysts Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) PT at $29.31 - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.9%Time to Buy? - MarketBeat
When is Nurix Therapeutics Inc. stock expected to show significant growthAdvanced Screener Data Feed To Watch Now - Jammu Links News
Nurix Therapeutics CFO Hans van Houte sells 5402 shares at $11.03 per share. - AInvest
Oppenheimer Reiterates "Outperform" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $51,691.04 in Stock - MarketBeat
Oppenheimer Reiterates Outperform Rating for Nurix Therapeutics (NRIX) | NRIX Stock News - GuruFocus
Oppenheimer Adjusts Price Target for Nurix Therapeutics (NRIX) - GuruFocus
Will Nurix Therapeutics Inc. benefit from macro trendsGrowth Focused Entry Plan Suggestions Issued - metal.it
ARK Investment Management LLC Has $18.90 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Real time social sentiment graph for Nurix Therapeutics Inc.Profit Focused Stock Screener Results Released - metal.it
Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock By Investing.com - Investing.com Australia
Nurix Therapeutics CFO van Houte sells $51,695 in shares By Investing.com - Investing.com South Africa
Nurix Therapeutics’ ring sells $46k in stock to cover tax obligations - Investing.com India
Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock - Investing.com
Nurix Therapeutics CFO van Houte sells $51,695 in shares - Investing.com
Will Nurix Therapeutics Inc. Hold Gains Into CloseMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Does Nurix Therapeutics Inc. stock pay reliable dividendsAI Trading Suggestions With Accuracy Focus Released - metal.it
Y Intercept Hong Kong Ltd Invests $374,000 in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
New York State Common Retirement Fund Boosts Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
NRIX Stock Price and Chart — NASDAQ:NRIX - TradingView
Nurix Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingTrade Insight With Community Collaboration Supported - metal.it
Does Nurix Therapeutics Inc. stock perform well during market downturnsFree Stock Selection - Jammu Links News
Nikko Asset Management Americas Inc. Lowers Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):